Clinical Research Directory
Browse clinical research sites, groups, and studies.
Precision Microbiota Interventions for Senoreduction Trial
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Summary
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Official title: Geroprotective Precision Medicine Strategies in PWH That Use Alcohol
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2026-04-01
Completion Date
2029-12-01
Last Updated
2026-03-10
Healthy Volunteers
No
Interventions
Limosilactobacillus reuteri
Administered as 6 capsules daily (3 twice daily) for 4 weeks. Each daily dose contains 1×10\^10 CFU total in a 1:1 ratio of two strains. This is a GRAS dietary supplement and not an FDA-regulated investigational product.
Blueberry extract
Administered as 6 capsules daily (3 twice daily) for 4 weeks, providing 500 mg anthocyanins per day. This is a GRAS dietary supplement and not an FDA-regulated investigational product.
Locations (1)
LSU Health
New Orleans, Louisiana, United States